Discover how obesity drugs may reduce alcohol consumption alongside weight loss. Learn about this promising new research.

Federal health agencies have restored several webpages and datasets, following a judge's order to bring back public access to information that had been removed to comply with a presidential executive ...

DFA alleges that the agencies violated the Administrative Procedure Act and the Paperwork Reduction Act by removing public ...

Part of the Trump administration's purge of the federal government included the removal of thousands of web pages. Now, some ...

Driver on probation arrested after high-speed pursuit in Visalia. Drugs, loaded handgun, and evidence of drug sales found in ...

The Food and Drug Administration announced it would decide by April 2024 whether chemical hair straightening products sold in the U.S. would be banned from using formaldehyde or ingredients that ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

They acknowledge the need for more testing to confirm drug safety and efficacy, but they suggest if these results translate to human patients, ErSO-TFPy could be transformative for ER+ breast ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...